The Pharmaceutical Market: South Africa

Date: January 31, 2013
Pages: 116
Price:
US$ 1,295.00
License [?]:
Publisher: Espicom Business Intelligence
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: P711A92BFFDEN
Leaflet:

Download PDF Leaflet

The Pharmaceutical Market: South Africa
OVERVIEW OF THE PHARMACEUTICAL MARKET IN SOUTH AFRICA

The government drive to support local production and reduce the country's reliance on imports, in addition to global epidemiological and demographic trends, are all positive factors contributing to long-term growth in the pharmaceutical market. However, deep segregation between private and public healthcare facilities continues to leave the vast majority of the population without medical care. BMI believes this will be rectified through the creation of the National Health Insurance scheme over the next decade, but in the meantime unemployment, lack of education and geographical inaccessibility to healthcare for the wider population will continue to hinder growth in the market.

Headline Expenditure Projections

Pharmaceuticals: ZAR27.19bn (US$3.74bn) in 2011 to ZAR29.61bn (US$3.61bn) in 2012; +8.9% in local currency and -3.5% in US dollar terms.

Healthcare: ZAR261.51bn (US$36.01bn) in 2011 to ZAR285.26bn (US$34.79bn) in 2012; +9.1% in local currency terms and -3.4% in US dollar terms.

Medical devices: ZAR11.43bn (US$1.57bn) in 2011 to ZAR12.19bn (US$1.49bn) in 2012; +6.7% in local currency terms and -5.5% in US dollar terms. Forecast changed due to depreciation of the South African rand.

Risk/Reward Rating: South Africa's composite score is unchanged at 55.5 out of 100, with no shift in position at sixth in the matrix out of 30 markets surveyed in the Middle East and Africa. Despite the country's low risk profile being more favourable than its rewards profile, the country remains one of the most attractive in the MEA region.

Competitive Landscape

The Competitive Landscape section provides comparative company analyses and rankings by US$ sales and % share of total sales - for the total pharmaceutical sector, as well as the OTC, generics, and distribution sub-sectors.
BMI INDUSTRY VIEW

SWOT

POLITICAL

ECONOMIC

BUSINESS ENVIRONMENT

INDUSTRY FORECAST

PHARMACEUTICAL MARKET FORECAST

   Table: Pharmaceutical Sales Indicators 2009-2017

PRESCRIPTION DRUG MARKET FORECAST

   Table: Prescription Drug Sales Indicators 2009-2017

PATENTED DRUG MARKET FORECAST

   Table: Patented Drug Market Indicators 2009-2017

GENERIC DRUG MARKET FORECAST

   Table: Generic Drug Sales Indicators 2009-2017

OTC MEDICINE MARKET FORECAST

   Table: OTC Medicine Sales Indicators 2009-2017

HEALTHCARE MARKET FORECAST

   Table: Healthcare Expenditure Indicators 2009-2017
   Table: Healthcare Governmental Indicators 2009-2017
   Table: Healthcare Private Indicators 2009-2017

PHARMACEUTICAL TRADE FORECAST

   Table: Exports and Imports Indicators 2009-2017

OTHER HEALTHCARE DATA

KEY RISKS TO BMI'S FORECAST SCENARIO

   Table: South Africa - Economic Activity

INDUSTRY RISK REWARD RATINGS

INDUSTRY RISK REWARD RATINGS

   Table: Middle East And Africa Pharmaceutical Risk/Reward Ratings, Q113

MARKET OVERVIEW

INDUSTRY TRENDS AND DEVELOPMENTS

   Table: Public Sector Hospitals By Province 2004-2011
   Table: Private Hospitals By Province 2004-2010
   Table: Public Sector Hospital Beds By Province 2005-2009
   Table: Private Sector Hospital Beds By Province 1998-2010

REGULATORY DEVELOPMENT

REGULATORY REGIME

   Table: Table: Drug Classification System
   Table: Table: Tiered Pharmaceutical Pricing System Is Better Than A Flat Fixed Mark-Up
   Table: Table: SEP Inflation, 2008-2011

COMPETITIVE LANDSCAPE

COMPANY PROFILE

ASPEN PHARMACARE

ADCOCK INGRAM

CIPLA MEDPRO

RANBAXY

SANOFI

PFIZER

ROCHE

GLAXOSMITHKLINE

MERCK & CO

NOVARTIS

DEMOGRAPHIC FORECAST

SOUTH AFRICA DEMOGRAPHIC DATA

   Table: South Africa's Population By Age Group, 1990-2020 ('000)
   Table: South Africa's Population By Age Group, 1990-2020 (% of total)
   Table: South Africa's Key Population Ratios, 1990-2020
   Table: South Africa's Rural And Urban Population, 1990-2020

METHODOLOGY

METHODOLOGY

  Risk/Reward Ratings Methodology
  Ratings Overview
   Table: Pharmaceutical Business Environment Indicators
  Weighting
   Table: Weighting Of Components
  Sources

GLOSSARY
Skip to top


Ask Your Question

The Pharmaceutical Market: South Africa
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: